The net outflow of the main market exceeded 10 billion.Huaru Technology: It has signed a substantial order in the field of intelligent robot targets. Huaru Technology said on the interactive platform that the intelligent robot targets developed by the company comprehensively use the Internet of Things, simulation, artificial intelligence and other advanced technologies to realistically simulate the combat actions of enemy soldiers or terrorists in complex battlefield environment, such as intelligent tracking, intelligent obstacle avoidance, automatic team formation, intelligent attack and defense, etc., and organize practical live-fire tactical confrontation training and inspection for special warfare troops, security forces and other organizations in urban blocks, architectural spaces and outdoor environments. The company has signed substantial orders in this field.Central Bank: On December 18th, 20 billion yuan of central bank bills will be issued. On December 18th, the People's Bank of China will issue the 12th issue of central bank bills in 2024 through the CMU bond bidding platform of the Hong Kong Monetary Authority. The 12th central bank bill has a maturity of 6 months (182 days), and is a fixed-rate interest-bearing bond, with a circulation of RMB 20 billion. The value date is December 20, 2024, and the maturity date is June 20, 2025, and the maturity date will be postponed in case of a holiday.
Russia said it would not make concessions on the Ukrainian issue and hoped to make contact with the US. Russian Foreign Ministry spokesman Zacharova said at a regular press conference on the 11th local time that Russia would not make concessions on the Ukrainian issue in response to the negotiation proposal put forward by US President-elect Trump on the 8th, and hoped to make contact with the US, but so far it has not received any "serious suggestions" from the team of US President-elect Trump. Zacharova also said that the recent statement of Ukrainian President Zelensky showed that "achieving peace is not a priority for Ukraine". Zelensky reiterated a few days ago that Uzbekistan will not sign any kind of peace agreement without security guarantee.The warm winter of second-hand houses has arrived: in November, house prices in Chengdu, Shenzhen rebounded first, and second-hand houses once again played a leading indicator of market warming. On December 11th, the Middle Finger Research Institute released a map of housing prices of second-hand houses in the top ten cities in November 2024, showing that in November, the average price of second-hand houses in Baicheng fell by 0.57% from the previous month, which was 0.03 percentage points lower than that of the previous month. The second-hand housing market in first-tier cities is more active. The average price of second-hand housing in the top ten cities dropped by 0.17% month-on-month, and the decline was narrowed by 0.16 percentage points from last month. Among them, the prices of second-hand houses in Shenzhen and Chengdu rose by 0.21% and 0.12% respectively, breaking the overall decline of 100 cities for seven consecutive months. Experts in the industry said that under the blessing of the policy of "buying houses and reducing taxes", it is expected that the transaction of second-hand houses in core cities will continue to be high, and prices are expected to continue to adjust. (beijing business today)The net outflow of the main market exceeded 10 billion.
Musk: Nothing is more beneficial to American health than "ultra-low-cost" diet pills. Musk advocates the use of diet pills to reduce American medical expenses. On December 11th, local time, Musk posted on social platform X that nothing can improve the health, longevity and quality of life of Americans better than very cheap GLP-1 drugs. He pointed out that most medical expenses occur at the end of life, and obesity is often an important factor leading to diseases. Therefore, popularizing GLP-1 drugs can save medical expenses on a long-term scale.The central parity of RMB against the US dollar was reported at 7.1854 yuan, down by 11 points.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide